Recent data indicates that retatrutide, a dual-action medication, could represent a major advance in weight management. This treatment combines the actions of a GLP-1 receptor and a GIP analog, possibly offering a enhanced outcome than available solutions. Clinical assessments have demonstrated promising results , including considerable decreases i